XML 15 R4.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Revenue:    
Product revenue $ 1,933,944 $ 1,921,052
Support and services revenue 3,060,005 4,118,063
Total revenue 4,993,949 6,039,115
Cost of revenue:    
Product 26,150 198,715
Support and service 728,888 1,253,916
Total cost of revenue 755,038 1,452,631
Gross profit 4,238,911 4,586,484
Operating expenses:    
Research and development costs 1,004,698 2,294,863
Selling and marketing 1,193,550 2,050,542
General and administrative 1,654,940 1,621,551
Restructuring costs (benefit) (173,263) (236,302)
Total operating expenses 3,679,925 5,730,654
Operating income (loss) 558,986 (1,144,170)
Interest and other income (loss), net 10,330 154,921
Income (Loss) before income taxes 569,316 (989,249)
Provision for income taxes 62,439 122,948
Net income (loss) 506,877 (1,112,197)
Less: Accrual of Series A redeemable convertible preferred stock dividends 243,167 204,575
Less: Deemed dividend on Series A redeemable convertible preferred stock 2,269,042 0
Less: Accretion to redemption value of Series A redeemable convertible preferred stock 38,105 0
Net loss attributable to common stockholders $ (2,043,437) $ (1,316,772)
Basic net loss per share attributable to common stockholders (in dollars per share) $ (0.05) $ (0.03)
Diluted net loss per share attributable to common stockholders (in dollars per share) $ (0.05) $ (0.03)
Weighted average basic shares outstanding (in shares) 44,564,094 44,088,352
Weighted average diluted shares outstanding (in shares) 44,564,094 44,088,352